Alligator Bioscience Comments on Henlius Presentation of HLX49 Preclinical Data at AACR 2026

AI Briefing

• – Alligator Bioscience announces Shanghai Henlius Biotech's presentation of HLX49 preclinical data at AACR 2026.
• – HLX49 is a HER2 biparatopic antibody targeting cancer cells.
• – Data supports the potential of HLX49 in treating HER2-positive cancers.